Missak Haigentz, MD, highlights some of the significant unmet needs for patients with small cell lung cancer.

AbbVie Inc. (NYSE:ABBV) is well-positioned to deliver a top-tier long-term outlook, driven by Humira’s success and strategic ...

Alicia Zhou, Ph.D., the incoming CEO at the Cancer Research Institute, talks about her plans and approach to moving a 70-year ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

On September 19, the FDA handed down its third amivantamab (Rybrevant; Johnson & Johnson) approval for 2024 in non–small cell lung cancer (NSCLC), giving the third-generation tyrosine kinase inhibitor ...

Following the FDA's green light for a combo regimen of Sanofi’s Sarclisa in patients with newly diagnosed multiple myeloma ...

Many patients who were treated at the Buffalo VA Medical Center experienced delays in treatment due to alleged negligence ...

Researchers are planning a clinical trial after four metastatic FGFR2 fusion-positive pancreatic cancer patients responded to ...

The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.

An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and ...

The current economic landscape presents a mix of signals as market participants assess the necessity of additional interest ...

Research shows that Black men are 70 percent more likely to develop prostate cancer. Here's why and what you need to know.